Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| VRX | Valeant Pharmaceuticals International, Inc. | 0.28% | 14.38 | 14.2% | $232.56m | |
| SHPG | Shire PLC Sponsored ADR | -1.62% | 145.55 | 0.4% | $212.81m | |
| PRGO | Perrigo Co. Plc | -0.49% | 77.31 | 6.4% | $151.41m | |
| MNK | Mallinckrodt Plc | 0.11% | 36.40 | 17.7% | $118.87m | |
| UTHR | United Therapeutics Corporation | -1.50% | 129.10 | 13.9% | $86.64m | |
| JAZZ | Jazz Pharmaceuticals Plc | -1.10% | 144.40 | 2.2% | $77.81m | |
| ENDP | Endo International Plc | 1.04% | 8.72 | 8.9% | $71.06m | |
| ALR | Alere Inc. | 0.43% | 49.54 | 2.7% | $68.28m | |
| HZNP | Horizon Pharma plc | 1.29% | 13.31 | 7.6% | $66.17m | |
| PRXL | PAREXEL International Corporation | 0.02% | 87.66 | 7.9% | $66.07m | |
| ICPT | Intercept Pharmaceuticals, Inc. | -0.11% | 104.08 | 22.1% | $61.01m | |
| NDRM | NeuroDerm Ltd. | 0.00% | 38.55 | 3.6% | $48.20m | |
| MYOK | MyoKardia, Inc. | -7.18% | 40.38 | 3.0% | $47.43m | |
| PTLA | Portola Pharmaceuticals, Inc. | 1.45% | 53.99 | 8.9% | $43.40m | |
| MDCO | Medicines Company | 0.28% | 35.50 | 22.3% | $41.20m |
Company Profile
Madrigal Pharmaceuticals, Inc. clinical-stage biopharmaceutical company. It focuses on the development and commercialization of novel compounds for the treatment of cardiovascular, metabolic and liver diseases. The company offers MGL-3196, an orally administered, small-molecule liver-directed ß-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. Madrigal Pharmaceuticals was founded by Rebecca Taub and Edward Chiang on September 2011 and is headquartered in Fort Washington, PA.